Professor Neil Garragher and Dr Simon Wilkinson at the Institute of Genetics and Cancer at the University of Edinburgh are investigating potential targeted therapies that interfere with molecular processes that pancreatic cancer require for survival. Two exciting targets are the metabolic process…
Read full research story →